These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 8908541

  • 1. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis.
    Remmel T, Piirsoo A, Koiveer A, Remmel H, Uibo R, Salupere V.
    Hepatogastroenterology; 1996; 43(11):1135-40. PubMed ID: 8908541
    [Abstract] [Full Text] [Related]

  • 2. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T, Gerken G, Meyer Zum Büschenfelde KH, Mayet WJ.
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Patterns of anti-nuclear antibodies in patients with primary biliary cirrhosis and primary Sjögren syndrome].
    You X, Liu W, Zhang X, Zhang FC.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 15; 88(3):168-70. PubMed ID: 18361813
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis.
    Bittencourt PL, Farias AQ, Abrantes-Lemos CP, Goncalves LL, Goncalves PL, Magalhães EP, Carrilho FJ, Laudanna AA, Cançado EL.
    J Gastroenterol Hepatol; 2004 Aug 15; 19(8):873-8. PubMed ID: 15242489
    [Abstract] [Full Text] [Related]

  • 8. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis.
    Granito A, Yang WH, Muratori L, Lim MJ, Nakajima A, Ferri S, Pappas G, Quarneti C, Bianchi FB, Bloch DB, Muratori P.
    Am J Gastroenterol; 2010 Jan 15; 105(1):125-31. PubMed ID: 19861957
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis.
    Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, Lenzi M, Rodrigo L, Linares A, Fuentes D, Bianchi FB.
    Am J Gastroenterol; 2003 Feb 15; 98(2):431-7. PubMed ID: 12591064
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis.
    Bernstein RM, Neuberger JM, Bunn CC, Callender ME, Hughes GR, Williams R.
    Clin Exp Immunol; 1984 Mar 15; 55(3):553-60. PubMed ID: 6368058
    [Abstract] [Full Text] [Related]

  • 13. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y.
    J Rheumatol; 2005 Aug 15; 32(8):1488-94. PubMed ID: 16078324
    [Abstract] [Full Text] [Related]

  • 14. [Antinuclear antibodies in primary biliary cirrhosis].
    Mzali S, Johanet C, Chrétien P, Abuaf N.
    Gastroenterol Clin Biol; 1989 Aug 15; 13(8-9):690-5. PubMed ID: 2680726
    [Abstract] [Full Text] [Related]

  • 15. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.
    Zhang FK, Jia JD, Wang BE.
    Hepatobiliary Pancreat Dis Int; 2004 May 15; 3(2):288-91. PubMed ID: 15138128
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
    Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, Heathcote EJ.
    Hepatology; 2002 Feb 15; 35(2):409-13. PubMed ID: 11826416
    [Abstract] [Full Text] [Related]

  • 18. Investigation and analysis of HEp 2 indirect immunofluorescence titers and patterns in various liver diseases.
    Wei Q, Jiang Y, Xie J, Yang M, Zhang Y, Wu Z, Chen S, Liao Z, Lin Z, Gu J.
    Clin Rheumatol; 2020 Aug 15; 39(8):2425-2432. PubMed ID: 32103375
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.